Victory Capital Management Inc. lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 14.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 228,573 shares of the company's stock after selling 39,024 shares during the period. Victory Capital Management Inc. owned about 0.26% of HealthEquity worth $21,932,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Keybank National Association OH bought a new stake in HealthEquity during the 4th quarter worth approximately $393,000. Charles Schwab Investment Management Inc. grew its holdings in HealthEquity by 2.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock worth $104,280,000 after buying an additional 25,004 shares in the last quarter. State of Michigan Retirement System raised its position in HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after buying an additional 100 shares during the last quarter. Silphium Asset Management Ltd bought a new position in HealthEquity during the 4th quarter valued at $2,639,000. Finally, Jones Financial Companies Lllp boosted its holdings in HealthEquity by 1,112.3% during the 4th quarter. Jones Financial Companies Lllp now owns 1,285 shares of the company's stock worth $123,000 after acquiring an additional 1,179 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.
Analysts Set New Price Targets
Several analysts have recently commented on the stock. The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Friday, November 15th. They issued a "neutral" rating and a $108.00 target price for the company. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Bank of America increased their price target on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a research report on Wednesday, November 13th. Finally, Raymond James boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Tuesday, February 25th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $113.54.
Get Our Latest Stock Report on HQY
Insider Activity
In related news, Director Stuart B. Parker sold 25,000 shares of the business's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.
HealthEquity Stock Up 1.3 %
Shares of NASDAQ HQY opened at $95.74 on Wednesday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $8.30 billion, a PE ratio of 87.83, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The business's fifty day moving average price is $105.75 and its 200-day moving average price is $94.80.
HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the previous year, the company earned $0.40 EPS. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.
HealthEquity Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.